Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC-Registry

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2018.06.006
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry

Clinical Genitourinary Cancer
OncologyUrology
2017English

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

High Expression of HMGA2 Predicts Poor Survival in Patients With Clear Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma

European Urology
Urology
2012English

Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2015English

Down-Regulation of TCF21 Is Associated With Poor Survival in Clear Cell Renal Cell Carcinoma

Neoplasma
Cancer Research
2012English

Clear Cell Papillary Renal Cell Carcinoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2015English

The Arkadia-Esrp2 Axis Suppresses Tumor Progression: Analyses in Clear-Cell Renal Cell Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy